| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0009500 | Exon-Exon | chr18:9204514-9221963 | chr18:9204516-9221965 | 29 nt | 0.3448 |
| hsa_ANKRD12_0010100 | Exon-Exon | chr18:9208655-9211782 | chr18:9208657-9211784 | 153 nt | 0.4118 |
| hsa_ANKRD12_0010200 | Exon-Exon | chr18:9208655-9216898 | chr18:9208657-9216900 | 491 nt | 0.4012 |
| hsa_ANKRD12_0010500 | Exon-Exon | chr18:9208661-9221997 | chr18:9208663-9221999 | 135 nt | 0.4000 |
| hsa_ANKRD12_0010600 | Exon-Exon | chr18:9208664-9221910 | chr18:9208666-9221912 | 199 nt | 0.4121 |
| hsa_ANKRD12_0010800 | Exon-Exon | chr18:9208777-9211782 | chr18:9208779-9211784 | 226 nt | 0.3850 |
| hsa_ANKRD12_0011500 | Exon-Exon | chr18:9211582-9263886 | chr18:9211584-9263888 | 105 nt | 0.4000 |
| hsa_ANKRD12_0011900 | Exon-Exon | chr18:9216756-9221997 | chr18:9216758-9221999 | 291 nt | 0.4261 |
| hsa_ANKRD12_0012000 | Intron-Exon-Intron | chr18:9216756-9239554 | chr18:9216758-9239556 | 143 nt | 0.4336 |
| hsa_ANKRD12_0011700 | Exon-Exon | chr18:9216756-9258929 | chr18:9216758-9258931 | 250 nt | 0.3240 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].